193 related articles for article (PubMed ID: 12788882)
1. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians.
Lindsay RS; Wake DJ; Nair S; Bunt J; Livingstone DE; Permana PA; Tataranni PA; Walker BR
J Clin Endocrinol Metab; 2003 Jun; 88(6):2738-44. PubMed ID: 12788882
[TBL] [Abstract][Full Text] [Related]
2. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific dysregulation of cortisol metabolism in human obesity.
Rask E; Olsson T; Söderberg S; Andrew R; Livingstone DE; Johnson O; Walker BR
J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
[TBL] [Abstract][Full Text] [Related]
4. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.
Nair S; Lee YH; Lindsay RS; Walker BR; Tataranni PA; Bogardus C; Baier LJ; Permana PA
Diabetologia; 2004 Jun; 47(6):1088-95. PubMed ID: 15156315
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
[TBL] [Abstract][Full Text] [Related]
6. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity.
Wake DJ; Rask E; Livingstone DE; Söderberg S; Olsson T; Walker BR
J Clin Endocrinol Metab; 2003 Aug; 88(8):3983-8. PubMed ID: 12915696
[TBL] [Abstract][Full Text] [Related]
7. Does central obesity reflect "Cushing's disease of the omentum"?
Bujalska IJ; Kumar S; Stewart PM
Lancet; 1997 Apr; 349(9060):1210-3. PubMed ID: 9130942
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
Baudrand R; Carvajal CA; Riquelme A; Morales M; Solis N; Pizarro M; Escalona A; Boza C; Pérez G; Domínguez A; Arrese M; Fardella CE
Obes Surg; 2010 Jan; 20(1):77-83. PubMed ID: 19690925
[TBL] [Abstract][Full Text] [Related]
9. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
Westerbacka J; Yki-Järvinen H; Vehkavaara S; Häkkinen AM; Andrew R; Wake DJ; Seckl JR; Walker BR
J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
[TBL] [Abstract][Full Text] [Related]
10. Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women.
Veilleux A; Rhéaume C; Daris M; Luu-The V; Tchernof A
J Clin Endocrinol Metab; 2009 Sep; 94(9):3550-7. PubMed ID: 19567539
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
Stewart PM; Toogood AA; Tomlinson JW
Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
[TBL] [Abstract][Full Text] [Related]
12. In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue.
Sutinen J; Kannisto K; Korsheninnikova E; Nyman T; Ehrenborg E; Andrew R; Wake DJ; Hamsten A; Walker BR; Yki-Järvinen H
Diabetologia; 2004 Oct; 47(10):1668-71. PubMed ID: 15455200
[TBL] [Abstract][Full Text] [Related]
13. Insulin attenuates the stimulatory effects of tumor necrosis factor alpha on 11beta-hydroxysteroid dehydrogenase 1 in human adipose stromal cells.
Handoko K; Yang K; Strutt B; Khalil W; Killinger D
J Steroid Biochem Mol Biol; 2000 Mar; 72(3-4):163-8. PubMed ID: 10775808
[TBL] [Abstract][Full Text] [Related]
14. 11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients.
Muñoz R; Carvajal C; Escalona A; Boza C; Pérez G; Ibáñez L; Fardella C
Obes Surg; 2009 Jun; 19(6):764-70. PubMed ID: 18592327
[TBL] [Abstract][Full Text] [Related]
15. Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity.
Tomlinson JW; Finney J; Gay C; Hughes BA; Hughes SV; Stewart PM
Diabetes; 2008 Oct; 57(10):2652-60. PubMed ID: 18633104
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.
Paulsen SK; Pedersen SB; Jørgensen JO; Fisker S; Christiansen JS; Flyvbjerg A; Richelsen B
J Clin Endocrinol Metab; 2006 Mar; 91(3):1093-8. PubMed ID: 16368752
[TBL] [Abstract][Full Text] [Related]
17. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children.
Zhu L; Hou M; Sun B; Burén J; Zhang L; Yi J; Hernell O; Li X
J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225
[TBL] [Abstract][Full Text] [Related]
18. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR
Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
[TBL] [Abstract][Full Text] [Related]
19. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
Stewart PM
Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
